NCT02468544

Brief Summary

This is an open-trial pilot study in which adult methadone maintenance treatment patients who are living with HIV but are not engaged in HIV primary care (i.e., missed appointments, non-adherence to medication) will be recruited to participate in a HIV primary care engagement study. The purpose of this study is to develop and test the feasibility and acceptability of a mobile phone-based health (mHealth) text messaging intervention to improve engagement in HIV primary care among substance abusing populations with HIV.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Mar 2017

Shorter than P25 for not_applicable hiv

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 31, 2015

Completed
11 days until next milestone

First Posted

Study publicly available on registry

June 11, 2015

Completed
1.7 years until next milestone

Study Start

First participant enrolled

March 1, 2017

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2017

Completed
Last Updated

November 9, 2020

Status Verified

November 1, 2020

Enrollment Period

1 month

First QC Date

May 31, 2015

Last Update Submit

November 6, 2020

Conditions

Keywords

Engagement in caremHealth

Outcome Measures

Primary Outcomes (2)

  • Acceptability of Intervention

    Acceptability of the intervention will be measured using the Technology Acceptance Model (TAM) scale.

    30 days

  • Feasibility of Intervention

    Feasibility of the intervention will be assessed focusing on study implementation, including recruitment and attrition rates.

    30 days

Secondary Outcomes (1)

  • Efficacy of the intervention

    30 days

Other Outcomes (2)

  • Self-efficacy to self-manage HIV infection

    30 days

  • Improvements in HIV knowledge

    30 days

Study Arms (1)

Single Arm Intervention Study

EXPERIMENTAL

All participants will receive individualized text messages based on a schedule determined during the development and refinement of the mHealth text messaging intervention (i.e., once or twice a week). All participants will receive text messages for: 1) medication reminders, 2) appointment reminders, and 3) text messages addressing barriers (educational information to improve HIV knowledge) or promoting facilitators (e.g., routinizing taking of HIV antiretroviral medication) of care engagement. Each participant will complete baseline assessments, and will select their preferences for personalized messages on the day of baseline assessments. Text messages will be deployed for the duration of the 30-day trial. Participants will be followed-up at the completion of the 30-day intervention. Each participant will be asked to complete a follow-up survey, including questions on the acceptability of the mHealth intervention.

Other: Text messaging

Interventions

Text messaging mHealth intervention to improve HIV Primary Care Engagement among clients of methadone maintenance treatment programs who are living with HIV.

Single Arm Intervention Study

Eligibility Criteria

Age18 Years - 55 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Client of a methadone maintenance treatment program
  • HIV positive (status confirmed by medical records)
  • At least 18 years of age
  • English speaking
  • Comfortable using a mobile phone (to send and receive text messages)
  • Lives in New York City
  • Willingness to attend at least two design sessions
  • Willingness to attend one usability testing session, and participate in a post-usability survey and exit interview.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Acacia Network/Promesa

New York, New York, 10457, United States

Location

Study Officials

  • Jemima A. Frimpong, PhD., MPH

    Columbia University

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 31, 2015

First Posted

June 11, 2015

Study Start

March 1, 2017

Primary Completion

April 1, 2017

Study Completion

April 1, 2017

Last Updated

November 9, 2020

Record last verified: 2020-11

Locations